Table 1 Characteristics across study period
Sham | VML | VML + MMG | VML + Tacrolimus | VML + MMG + Tacrolimus | |
|---|---|---|---|---|---|
n= | 1 | 2 | 4 | ||
Body mass (kg) | |||||
Week 0 | 39.4 ± 0.0 | 41.9 ± 2.3 | 41.7 ± 0.8 | ||
Week 4 | 48.6 ± 0.0 | 49.9 ± 3.1 | 46.5 ± 0.7 | ||
Week 8 | 54.2 ± 0.0 | 56.6 ± 2.8 | 51.8 ± 2.8 | ||
Week 12 | 61.2 ± 0.0 | 65.3 ± 3.9 | 55.7 ± 3.3 | ||
Tacrolimus concentration (ng/ml) | |||||
Day 3 | nd | nd | 1.12 ± 0.29 | ||
Day 9 | nd | nd | 1.35 ± 0.14 | ||
Week 2 | nd | nd | 1.73 ± 0.25 | ||
Week 3 | nd | nd | 2.26 ± 0.65 | ||
Week 4 | nd | nd | 3.25 ± 1.58 | ||
Week 6 | nd | nd | nd | ||